Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Nestle raises guidance after Q3 sales beat expectations

Americas, pet food, health science were drivers

Article originally published by Reuters. Hargreaves Lansdown is not responsible for its content or accuracy and may not share the author's views. News and research are not personal recommendations to deal. All investments can fall in value so you could get back less than you invest.

Nestle raised its guidance for 2020 organic sales growth to around 3% after beating third-quarter expectations on Wednesday with 4.9% growth driven by strong demand for pet food and health products.

The world's biggest food group has weathered the COVID-19 pandemic better than some peers thanks to its broad portfolio helping offset a slump in food sales to restaurants and cafes.

Shares in Nestle, up 2.5% so far this year, were indicated to open 2.7% higher in pre-market trading.

Demand for food and drinks consumed at home remained strong during the pandemic, while sales of products destined to out-of-home venues struggled, the maker of Nescafe coffee and KitKat chocolate said in a statement.

Nestle said it wanted it keep developing its portfolio, notably expanding its health science business recently bolstered by the $2 billion Aimmune Therapeutics acquisition.

For the first nine months of the year, Nestle's organic sales grew by 3.5%, beating the 2.8% in a company-supplied consensus analysts' estimates.

Nestle had previously expected organic growth of 2-3% for this year. It confirmed it wanted to improve its margin.

Nestle Sa

Sell: 101.46 | Buy: 101.48 negative 2.22 (-2.14%)
Graph
Prices delayed by at least 15 minutes.

Sales in the Americas posted the strongest growth rate in the nine-month period, while Asia was only slightly positive.

Sales in Swiss francs fell 9.4% to 61.9 billion Swiss francs ($68.33 billion) hit by divestitures.

Under Chief Executive Mark Schneider, Nestle divested its skin health unit, Herta meat and U.S. ice cream brands and has put North American waters and peanut milk label Yinlu under strategic review.

Nestle said both reviews were on track and were expected to be completed in early 2021.

French peer Danone announced an extensive review this week that could lead to disposals after its like-for-like sales fell 2.5% in the third quarter.

Unilever is due to release a trading statement on Thursday.

($1 = 0.9059 Swiss francs) (Reporting by Silke Koltrowitz, editing by John Revill)


Copyright (2020) Thomson Reuters. This article was written by Silke Koltrowitz from Reuters and was legally licensed through the Industry Dive publisher network. Please direct all licensing questions to legal@industrydive.com.

Article originally published by Reuters. Hargreaves Lansdown is not responsible for its content or accuracy and may not share the author's views. News and research are not personal recommendations to deal. All investments can fall in value so you could get back less than you invest.

Free news email alerts

  • Daily and weekly news
  • Major Publishers
Register